340570.KQ T&L Co. Ltd

Healthcare Health Care Equipment & Supplies KOSDAQ
23,750 KRW
Close of Nov 1, 2026
21,072 35,800
Market cap
KRW 377B
P/E
7.6x
P/B
1.68x
ROE
32.5%
Dividend yield
1.60%
Fundamental score
3.2/5

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 340570.KQ undervalued?

Graham number
Price23,750
Graham value31,533
Discount24.7%

340570.KQ trades 24.7% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

T&L Co. Ltd fundamental analysis

15 of 22 checks passed

ROE 2/2

High return on equity (32.5%), above 20%.

ROA 1/1

Return on assets (28.7%) is above the industry median (6.2%).

Profit Consistency 2/2

Profitable for 9 consecutive years.

Earnings Growth 5Y 1/1

Earnings per share grew over the past 5 years.

Earnings Acceleration 0/1

Last year's EPS growth (-58.7%) is not above the 5-year average (14.0% a year).

Earnings Growth vs Industry 0/1

Last year's EPS growth (-58.7%) is below the industry median (0.5%).

Revenue Growth 2/2

Revenue grew 26.2% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 0/2

Debt to equity cannot be calculated: debt is not reported or equity is negative.

Debt Trend 0/1

Debt to equity has risen over the past 5 years.

Debt Coverage 0/1

Debt is not reported.

Interest Coverage 1/1

EBIT is 14,835.1x against interest expense, well covered.

PE vs Market 1/1

PE (7.6x) is below the market median (11.3x).

PE vs Industry 0/1

PE (7.6x) is above the industry median (7.6x).

PBV 0/1

Price to book (1.7x) is above the industry median (0.7x).

Graham Number 1/1

The price is below the Graham number (PE x PB = 12.8, limit 22.5).

PEG 1/1

PEG on 5-year earnings growth is 0.54, growth is cheap.

Dividend Yield 1/2

Dividend yield (1.6%) is above the bottom 25% of dividend payers in the market.

Dividend Stability 1/2

Dividends paid without a cut of more than 10% for 7 years.

Dividend Growth 1/1

Dividends paid grew over the past 5 years.

Payout Ratio 1/1

Payout ratio is 15.9%, covered by earnings.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

T&L Co. Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About T&L Co. Ltd

T&L Co., Ltd. engages in the manufacture and sale of medical and polymer material products in South Korea. Its chemical products include water borne resins, hardeners, functional additives, and urethane foam; wound care products, including hydrocolloid, foam, hydrogel, silicone, alginate, and other products; and orthopedic products, such as cast, splint, and other products. T&L Co., Ltd. was founded in 1998 and is headquartered in Yongin-si, South Korea.

Full company profile